August 7, 2015 — The American College of Cardiology (ACC) has announced that Boehringer Ingelheim is the newest industry ...
August 5, 2015 — Boehringer Ingelheim announced the first U.S. patients have been enrolled in two of the company's ...
July 7, 2015 - Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of ...
April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner ...
June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...
December 15, 2010 – A guest editorial in the new publication Clinical Investigation highlights dabigatran etexilate as ...
October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and blood ...
October 4, 2010 – The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee voted 9 ...